4//SEC Filing
WEIL JOHN D 4
Accession 0000904314-18-000001
CIK 0000874710other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 2:03 PM ET
Size
24.0 KB
Accession
0000904314-18-000001
Insider Transaction Report
Form 4
WEIL JOHN D
Director10% Owner
Transactions
- Other
Common Stock
2018-08-20−357,304→ 137,735 total(indirect: By Partnership) - Other
Common Stock
2018-08-20+36,936.5→ 90,513.5 total
Holdings
- 59,101(indirect: By Trust)
Common Stock
- 1,500
Option (right to buy)
Exercise: $4.34From: 2011-11-11Exp: 2020-11-11→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $2.31From: 2014-11-14Exp: 2023-11-14→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $1.17From: 2016-11-12Exp: 2025-11-12→ Common Stock (1,500 underlying) - 750
Option (right to buy)
Exercise: $2.22From: 2018-11-09Exp: 2027-11-09→ Common Stock (750 underlying) - 2,500(indirect: By IRA)
Common Stock
- 94,427(indirect: By Spouse)
Common Stock
- 7,927(indirect: Corporation)
Common Stock
- 119,792(indirect: By Trust)
Common Stock
- 1,500
Option (right to buy)
Exercise: $4.05From: 2009-11-13Exp: 2018-11-13→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $5.04From: 2010-11-13Exp: 2019-11-13→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $3.56From: 2012-11-10Exp: 2021-11-10→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $2.59From: 2013-11-08Exp: 2022-11-08→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $1.58From: 2015-11-13Exp: 2024-11-13→ Common Stock (1,500 underlying) - 1,500
Option (right to buy)
Exercise: $1.13From: 2017-11-10Exp: 2026-11-10→ Common Stock (1,500 underlying)
Footnotes (8)
- [F1]Shares acquired in a transfer for no consideration from a family limited partnership, as reported on this Form 4 in the last line item of this Table 1, which transaction is exempt from Section 16 pursuant to Rule 16a-13.
- [F2]The reporting person disclaims any economic benefit in such shares.
- [F3]Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
- [F4]Shares disposed of in a transfer for no consideration from a family limited partnership to the reporting person and members of the reporting person's family, in a transaction exempt from Section 16 pursuant to Rule 16a-13, including the transfer of 36,963.50 shares to the reporting person's direct ownership as reported on this Form 4 in the first line item of the Table 1.
- [F5]Owned by a corporation controlled by the reporting person.
- [F6]Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares.
- [F7]Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.
- [F8]Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B)
Documents
Issuer
ALLIED HEALTHCARE PRODUCTS INC
CIK 0000874710
Entity typeother
IncorporatedMO
Related Parties
1- filerCIK 0000904314
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 2:03 PM ET
- Size
- 24.0 KB